Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 18

1.

Measles Pneumonitis.

Schoini P, Karampitsakos T, Avdikou M, Athanasopoulou A, Tsoukalas G, Tzouvelekis A.

Adv Respir Med. 2019 Mar 4. doi: 10.5603/ARM.a2019.0010. [Epub ahead of print]

2.

Vitamin D prevents experimental lung fibrosis and predicts survival in patients with idiopathic pulmonary fibrosis.

Tzilas V, Bouros E, Barbayianni I, Karampitsakos T, Kourtidou S, Ntassiou M, Ninou I, Aidinis V, Bouros D, Tzouvelekis A.

Pulm Pharmacol Ther. 2019 Apr;55:17-24. doi: 10.1016/j.pupt.2019.01.003. Epub 2019 Jan 16.

PMID:
30659895
3.

Coexistence of Tracheobronchopathia Osteochondroplastica and Sarcoidosis: Accidental Finding or Something More?

Chrysikos S, Karampitsakos T, Tzouvelekis A, Dimakou K.

J Bronchology Interv Pulmonol. 2019 Jan;26(1):e7-e8. doi: 10.1097/LBR.0000000000000521. No abstract available.

PMID:
30562285
4.

Endobronchial metastasis from renal cell carcinoma as a reason for recurrent pulmonary infections.

Chrysikos S, Karampitsakos T, Tzouvelekis A, Dimakou K.

Adv Respir Med. 2018;86(5):245-248. doi: 10.5603/ARM.2018.0039.

5.

Early Career Members at the ERS Lung Science Conference: cell-matrix interactions in lung disease and regeneration: Early career forum.

Almendros I, Alsafadi HN, Bölükbas D, Collins JJP, Duch P, Garrido-Martin EM, Kahn N, Karampitsakos T, Mahmutovic Persson I, Tzouvelekis A, Uhl FE, Bartel S.

Breathe (Sheff). 2018 Jun;14(2):e78-e83. doi: 10.1183/20734735.016818.

6.

Mesenchymal Stem Cells for the Treatment of Idiopathic Pulmonary Fibrosis.

Tzouvelekis A, Toonkel R, Karampitsakos T, Medapalli K, Ninou I, Aidinis V, Bouros D, Glassberg MK.

Front Med (Lausanne). 2018 May 15;5:142. doi: 10.3389/fmed.2018.00142. eCollection 2018. Review.

7.

Pulmonary hypertension in patients with interstitial lung disease.

Karampitsakos T, Tzouvelekis A, Chrysikos S, Bouros D, Tsangaris I, Fares WH.

Pulm Pharmacol Ther. 2018 Jun;50:38-46. doi: 10.1016/j.pupt.2018.03.002. Epub 2018 Mar 29. Review.

PMID:
29605286
8.

A Rare Case of Primary Intrapulmonary Neurilemmoma Diagnosed in a 43-Year-Old Asymptomatic Man with a Well-defined Intrapulmonary Mass.

Chrysikos S, Kaponi M, Triantafillidou C, Karampitsakos T, Tzouvelekis A, Anyfanti M, Marossis K, Konstantinou M, Tringidou R, Bouros D, Dimakou K.

Front Oncol. 2018 Jan 30;8:11. doi: 10.3389/fonc.2018.00011. eCollection 2018.

9.

Metabolic Disorders in Chronic Lung Diseases.

Papaioannou O, Karampitsakos T, Barbayianni I, Chrysikos S, Xylourgidis N, Tzilas V, Bouros D, Aidinis V, Tzouvelekis A.

Front Med (Lausanne). 2018 Jan 18;4:246. doi: 10.3389/fmed.2017.00246. eCollection 2017. Review.

10.

Corrigendum: Longitudinal "Real-World" Outcomes of Pirfenidone in Idiopathic Pulmonary Fibrosis in Greece.

Tzouvelekis A, Karampitsakos T, Ntolios P, Tzilas V, Bouros E, Markozannes E, Malliou I, Anagnostopoulos A, Granitsas A, Steiropoulos P, Dimakou K, Chrysikos S, Koulouris N, Bouros D.

Front Med (Lausanne). 2018 Jan 24;4:257. doi: 10.3389/fmed.2017.00257. eCollection 2017.

11.

Safety and efficacy of nintedanib in idiopathic pulmonary fibrosis: A real-life observational study in Greece.

Tzouvelekis A, Karampitsakos T, Kontou M, Granitsas A, Malliou I, Anagnostopoulos A, Ntolios P, Tzilas V, Bouros E, Steiropoulos P, Chrysikos S, Dimakou K, Koulouris N, Bouros D.

Pulm Pharmacol Ther. 2018 Apr;49:61-66. doi: 10.1016/j.pupt.2018.01.006. Epub 2018 Jan 31.

PMID:
29366978
12.

Longitudinal "Real-World" Outcomes of Pirfenidone in Idiopathic Pulmonary Fibrosis in Greece.

Tzouvelekis A, Karampitsakos T, Ntolios P, Tzilas V, Bouros E, Markozannes E, Malliou I, Anagnostopoulos A, Granitsas A, Steiropoulos P, Dimakou K, Chrysikos S, Koulouris N, Bouros D.

Front Med (Lausanne). 2017 Nov 29;4:213. doi: 10.3389/fmed.2017.00213. eCollection 2017. Erratum in: Front Med (Lausanne). 2018 Jan 24;4:257.

13.

The effect of bronchodilation and spirometry on fractional exhaled nitric oxide (FeNO50), bronchial NO flux (JawNO) and alveolar NO concentration (CANO) in children and young adults.

Karampitsakos T, Protopapas A, Gianoloudi M, Papadopoulos VP, Bouros D, Chatzimichael A, Paraskakis E.

J Asthma. 2018 Aug;55(8):882-889. doi: 10.1080/02770903.2017.1373807. Epub 2017 Oct 11.

PMID:
28949783
14.

Safety and efficacy of pirfenidone in severe Idiopathic Pulmonary Fibrosis: A real-world observational study.

Tzouvelekis A, Ntolios P, Karampitsakos T, Tzilas V, Anevlavis S, Bouros E, Steiropoulos P, Koulouris N, Stratakos G, Froudarakis M, Bouros D.

Pulm Pharmacol Ther. 2017 Oct;46:48-53. doi: 10.1016/j.pupt.2017.08.011. Epub 2017 Aug 24.

PMID:
28843616
15.

Lung cancer in patients with idiopathic pulmonary fibrosis.

Karampitsakos T, Tzilas V, Tringidou R, Steiropoulos P, Aidinis V, Papiris SA, Bouros D, Tzouvelekis A.

Pulm Pharmacol Ther. 2017 Aug;45:1-10. doi: 10.1016/j.pupt.2017.03.016. Epub 2017 Apr 1. Review.

PMID:
28377145
16.

Toll-like receptors in the pathogenesis of pulmonary fibrosis.

Karampitsakos T, Woolard T, Bouros D, Tzouvelekis A.

Eur J Pharmacol. 2017 Aug 5;808:35-43. doi: 10.1016/j.ejphar.2016.06.045. Epub 2016 Jun 27. Review.

PMID:
27364757
17.

Asthma-COPD Overlap Syndrome (ACOS): Single disease entity or not? Could exhaled nitric oxide be a useful biomarker for the differentiation of ACOS, asthma and COPD?

Karampitsakos T, Gourgoulianis KI.

Med Hypotheses. 2016 Jun;91:20-23. doi: 10.1016/j.mehy.2016.04.008. Epub 2016 Apr 8.

PMID:
27142135
18.

Greek Physicians' Perceptions on Generic Drugs in the Era of Austerity.

Labiris G, Fanariotis M, Kastanioti C, Alexias G, Protopapas A, Karampitsakos T, Niakas D.

Scientifica (Cairo). 2015;2015:251792. doi: 10.1155/2015/251792. Epub 2015 Sep 17.

Supplemental Content

Loading ...
Support Center